Researchers Find Boosting Depression-Causing Mechanisms in the Brain Increases Resilience, Surprisingly
April 17, 2014
New antidepressant approach potentially promotes natural resilence, fewer side effects.
Paul J. Kenny, PhD, Named Chair of Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai
October 11, 2013
Dr. Kenny plans to build a hub for small molecule development and next generation therapeutics.
Chemical Compound Shows Promise as Alternative to Opioid Pain Relievers
July 1, 2013
Drug targeting a protein complex containing two different types of opioid receptors may be an effective alternative to morphine and other opioid pain medications.
Mount Sinai Researchers Unveil New Targets for Depression at Neuroscience 2012
October 15, 2012
Scientists presented important discoveries on the involvement of the immune system and dopamine on the onset of depression.
Mount Sinai Researchers Develop New Computational Method to Find Novel Connections from Gene to Gene, Drug to Drug and Between Scientists
July 23, 2012
New algorithm will change how scientists build networks from data to help predict gene and drug interactions.
Researchers Discover Drug Target for Kidney Failure
March 11, 2012
Mount Sinai researchers used computer software to help identify a protein that plays a crucial role in kidney fibrosis, which leads to kidney failure, a disease that affects millions of Americans.
Systems Biology Center New York Accepting Applications for the 2012 Summer Undergraduate Research Program
November 11, 2011
City University of New York undergraduates interested in an intensive summer research training experience in computational systems biology are invited to apply.
Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health
October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science.
Mount Sinai Researchers Develop New Computational Method to Aid Analysis of Gene Expression Experiments
September 15, 2010
Mount Sinai researchers have developed a new database that will change how scientists identify drug targets and biomarkers.
Researchers Identify New Therapeutic Targets to Improve Pain Management After Chronic Morphine Administration
September 7, 2010
Researchers identified changes in the brain and spinal cord that occur during the development of morphine tolerance, providing a therapeutic target for preventing it.
Mount Sinai Researchers Reveal Novel Structural Features at the Core of Cellular Energy Conversion
August 18, 2010
The research team determined that the cellular nanomachine, or motor, uses a water molecule to convert food energy into usable cellular energy.
Mount Sinai School of Medicine Researchers Discover Mechanism by Which Diseases Develop
July 8, 2010
Researchers have identified a previously unknown mechanism by which information from a gene is used to direct the physical and behavioral development of individuals.
Mount Sinai Honors Female Scientists with Inaugural Robin Chemers Neustein Postdoctoral Fellowship
June 30, 2010
Inaugural award supporting female scientists at Mount Sinai School of Medicine has been awarded to Molly A. Ingersoll, PhD, and Ruth I. Johnson, PhD.
Mount Sinai Discovers Genetic Framework to Explain and Predict Adverse Drug Reactions
April 20, 2010
Researchers at Mount Sinai School of Medicine have taken a step toward the ability to predict adverse drug reactions, such as heart arrhythmias.
Yasmin L. Hurd, PhD, Named Director of MD-PhD Program at Mount Sinai School of Medicine
April 2, 2010
Yasmin L. Hurd, PhD, has been appointed Director of the MD/PhD program at Mount Sinai School of Medicine. Her appointment is effective April 1.